SELECTION

Two Scientific Committees, each consisting of international experts in ASMD and Pompe disease, will evaluate applications and select up the winning abstracts.

Sanofi withdraws itself from any decisions linked to the selection of the winning applications and leaves the entire management of the submitted applications to these experts and GK Pharmacomm. Sanofi will not play any role in the review or selection process.

Each qualifying application will be anonymized before being reviewed by the entire relevant Scientific Committee. The only exception will be if a Scientific Committee member is working in the same country as the country of residence of the applicant. In this instance, that Scientific Committee member will be excluded from reviewing the relevant application.

Each application will be assessed by the Scientific Committee for novelty, relevance for clinical practice, and overall quality.